|
ABVC ABVC Biopharma Inc 1173313 |
| Balance Sheet |
|
Current Assets
|
$411,729.00 |
|
Assets
|
$19,400,715.00 |
|
Current Liabilities
|
$5,694,505.00 |
|
Liabilities
|
$7,131,155.00 |
|
Equity
|
$10,287,183.00 |
|
Shares Out
|
25767664.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,138,656.00 |
|
Investing Cash Flow
|
$-54,408.00 |
| Market Analysis |
Market Cap
|
$22,933,220.96 |
|
Price
|
$0.89 |
|
BVPS
|
0.40 |
|
PB
|
2.23 |
|
EPS
|
-0.03 |
|
PS
|
77.48 |
|
FCF
|
$-8,538,656.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:46 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ABVC documents filed with the SEC.
ABVC Filings
Clear
